Insider · CIK 0001851420
Peter Behner
Files at INKT (MiNK Therapeutics, Inc.). First filing -, latest -.
In brief
Peter Behner files SEC Form 4 as director at INKT (MiNK Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Peter Behner has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +1,485 | $10.95 | $16k | 24,404 | 42 d ago |
| Mar 2, 2026 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +1,491 | $10.90 | $16k | 21,606 | Jun 2, 2026 |
| Jun 1, 2026 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +1,313 | $12.38 | $16k | 22,919 | Jun 2, 2026 |
| Jan 2, 2026 | INKT MiNK Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +5,395 | $0.00 | $0 | 5,395 | Jan 6, 2026 |
| Dec 1, 2025 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +1,466 | $11.09 | $16k | 20,115 | Dec 3, 2025 |
| Sep 9, 2025 | INKT MiNK Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +3,225 | $0.00 | $0 | 3,225 | Sep 11, 2025 |
| Sep 2, 2025 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +1,173 | $13.86 | $16k | 18,649 | Sep 3, 2025 |
| Jun 2, 2025 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +2,267 | $7.17 | $16k | 17,476 | Jun 4, 2025 |
| Mar 3, 2025 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +1,849 | $8.79 | $16k | 15,209 | Mar 5, 2025 |
| Dec 1, 2024 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +20,987 | $0.73 | $15k | 133,634 | Dec 3, 2024 |
| Mar 1, 2024 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +16,185 | $0.95 | $15k | 75,027 | Mar 5, 2024 |
| Dec 1, 2023 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +14,784 | $1.04 | $15k | 58,842 | Dec 5, 2023 |
Questions about Peter Behner
Answered from the filings on this page, as of the latest one.
Is Peter Behner buying or selling?
Peter Behner has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Peter Behner's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Peter Behner has 0.
Where does Peter Behner file Form 4?
Peter Behner has filed Form 4 at INKT (MiNK Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.